Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionProduct descriptionProduct informationDosing and administration

Administration

10 evidence topics · 11 sources

Phase 2b dosing session procedures and 12-hour monitoring

“On the dosing day, participants received a single oral dose of MM120 or placebo.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Each participant was continuously monitored on-site for safety and comfort by the same 2 dosing session monitors who conducted the participant’s educational session during the baseline visit.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Participant dosing sessions were conducted individually in a private aesthetically pleasant room.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Participants were offered standardized music and eyeshades and they could lie down, move freely around the room, read, write, or draw.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Vital signs were measured throughout the dosing session and a physician was on-site in case comfort medications were needed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Starting 8 hours after the dose, participants were assessed hourly to characterize the resolution of the drug effects.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Continuous monitoring was required for a minimum of 12 hours.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote